243
Betreute Anmeldungen
Technische BereichePatente
Pharmazeutika116
Organische Feinchemie80
Biotechnologie38
Chemietechnik4
Lebensmittelchemie4

Heimatländer der Klienten

Zusammenfassung

AHN, So-Young ist besonders erfahren in den Technologien „Pharmazeutika“ und „Organische Feinchemie“. 79% aller Patente wurden im Bereich „(Bio-)Chemie“ betreut. Die wichtigsten Klienten sind „HANALL BIOPHARMA CO., LTD.“ und „BORYUNG PHARMACEUTICAL CO., LTD.“. Besonders viele Patentanmeldungen wurden in den Jahren 2014 und 2011 betreut. Die Klienten stammen oftmals aus Korea, Rep..

Patente nach Jahren

Patente nach Bereichen

3
Patentanmeldungen
192
Patentanmeldungen
1
Patentanmeldungen

Patente nach Anmeldern

RangNameLandPatente
1HANALL BIOPHARMA CO., LTD.Korea, Rep.26
2BORYUNG PHARMACEUTICAL CO., LTD.Korea, Rep.22
3UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITYKorea, Rep.20
4CHONG KUN DANG PHARMACEUTICAL CORP.Korea, Rep.19
5EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATIONKorea, Rep.17
6DONG-A PHARM. CO., LTD.Korea, Rep.15
7KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGYKorea, Rep.11
8DONG WHA PHARM. IND. CO., LTD.Korea, Rep.8
9JEIL PHARMACEUTICAL CO., LTD.Korea, Rep.7
10KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCESKorea, Rep.6
11SNU R&DB FOUNDATIONKorea, Rep.6
12YUHAN CORPORATIONKorea, Rep.6
13DONG-A ST CO., LTDKorea, Rep.5
14SOONCHUNHYANG UNIVERSITY INDUSTRY ACADEMY COOPERATION FOUNDATIONKorea, Rep.5
15ST PHARM CO., LTD.Korea, Rep.5
16NEUMEDKorea, Rep.4
17CBSBIOSCIENCEKorea, Rep.3
18CELL & BIO CO., LTD.Korea, Rep.3
19CHO-A PHARM CO., LTD.Korea, Rep.3
20JEON, SOOK-YEONGKorea, Rep.3
21KOREA UNIVERSITY INDUSTRIAL & ACADEMIC COLLABORATION FOUNDATIONKorea, Rep.3
22KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATIONKorea, Rep.3
23LEE, YOUNG JOOUSA3
24NAHM, DONG-HOKorea, Rep.3
25SAMCHULLY CO., LTD.Korea, Rep.3

Letzte Anmeldungen

PublikationsnummerTitelPatentanmelderJahr
WO2016209036METHOD FOR SCREENING INHIBITOR AGAINST IMMUNOSUPPRESSION BY HOPQ1 USING INTERACTION OF TYPE III EFFECTOR HOPQ1 AND LIM DOMAIN KINASE 1 (LIMK1) AND COMPOSITION THEREFORKOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
2016
WO2016204376NOVEL INTERMEDIATES FOR PREPARING DPP-IV INHIBITORS, PREPARING METHOD THEREOF AND PREPARING METHOD OF DPP-IV INHIBITORS USING THE SAMEKYUNG DONG PHARM. CO., LTD.
2016
WO2016200101TRICYCLIC DERIVATIVE COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAMEJEIL PHARMACEUTICAL CO., LTD.
2016
WO2016190630HETEROCYCLICALKYL DERIVATIVE COMPOUNDS AS SELECTIVE HISTONE DEACETYLASE INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAMECHONG KUN DANG PHARMACEUTICAL CORP.
2016
WO2016167577COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES OR PAINYUHAN CORPORATION
2016
WO2016163757ANTIVIRAL AGENT-SENSITIVE/RESISTANT VIRUS DETECTION SYSTEMKOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
2016
WO2016159405KNOCK-IN VECTOR FOR HUMANIZING OCT2 GENE IN MICESEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
2016
WO2016159666CRYSTAL FORM AND PREPARATION METHOD THEREFORDAE WON PHARMACEUTICAL CO.,LTD
2016
WO2016153263METHOD FOR CULTURING DIFFERENTIATION-PROMOTING AND -SUSTAINING SPHEROID FORM OF TONSIL-DERIVED STEM CELLSEWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION
KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
2016
WO2016126012TABLET AND METHOD OF PREPARING THE SAMEBORYUNG PHARMACEUTICAL CO., LTD.
2016
WO2016122014METHOD FOR MASS-PRODUCING NATURAL KILLER CELLS AND USE OF NATURAL KILLER CELLS OBTAINED BY THE METHOD AS ANTICANCER AGENTKOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
2016
WO2016122057LIPOSOME COMPOSITION USING SUGAR ALCOHOL WITH ADJUSTED SURFACE AREA AND/OR POROSITY AS CARRIER AND METHOD FOR PREPARING SAMESOONCHUNHYANG UNIVERSITY INDUSTRY ACADEMY COOPERATION FOUNDATION
2016
WO2016122147METHOD FOR MASS PRODUCING NATURAL KILLER CELL AND USE OF NATURAL KILLER CELL OBTAINED BY THE METHOD AS ANTI-CANCER AGENTKOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
2016
WO2016114621COMPOSITION FOR PREVENTION OR TREATMENT OF METABOLIC BONE DISEASES COMPRISING COMBINED EXTRACT OF SCHISANDRA CHINESIS, EUCOMMIAE CORTEX AND LYCIUM CHINENSE AS ACTIVE INGREDIENTUNIVERSUTY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
2016
WO2016105172A METHOD FOR PREPARING GADOBUTROLST PHARM CO., LTD.
2016
WO2016072748PHARMACEUTICAL COMPOSITIONS COMPRISING LOBEGLITAZONE FOR ORAL ADMINISTRATIONCHONG KUN DANG PHARMACEUTICAL CORP.
2016
WO2016068427INTERLEUKIN-2 EXPRESSION CONSTRUCT USING HUMAN SERUM ALBUMINSOONCHUNHYANG UNIVERSITY INDUSTRY ACADEMY COOPERATION FOUNDATION
2016
WO2016068428METHOD FOR PRODUCING INTERLEUKIN-2 PROTEIN USING METHYLOTROPHIC YEASTSOONCHUNHYANG UNIVERSITY INDUSTRY ACADEMY COOPERATION FOUNDATION
2016
WO2016068663MICROFLUIDIC DEVICE FOR DETECTING TARGET GENE, METHOD FOR MANUFACTURING SAME, AND METHOD FOR DETECTING USING SAMEKOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION
2016
WO2016064231METHOD FOR PREDICTING SENSITIVITY TO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR INHIBITORGIL MEDICAL CENTER
CBSBIOSCIENCE
2016
WO2016060525COMPOSITION CONTAINING EXTRACT OR FRACTION OF GENUS PLANTDONG WHA PHARM. IND. CO., LTD.
2016
WO2016052960BITTER TASTE-MASKED, ONDANSETRON ORALLY DISINTEGRATING FILMSEOUL PHARMA. CO., LTD.
2016
WO2016043462METHOD FOR PREPARING CALCOBUTROLST PHARM CO., LTD.
2016
WO2016036093TADALAFIL ORAL DISPERSIBLE FILM AND PREPARING METHOD THEREOFSEOUL PHARMA. CO., LTD.
2016
WO2016024753COSMETIC COMPOSITION FOR IMPROVING SKIN WRINKLESUNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
DONGGUK UNIVERSITY GYEONGJU CAMPUS INDUSTRY-ACADEMY COOPERATION FOUNDATION
2016
...